Cart
sales@molnova.com
FAUC 346
CAS No. 474432-65-0
FAUC 346( —— )
Catalog No. M24423 CAS No. 474432-65-0
FAUC 346 is a highly selective D3 partial agonist with EC50 of 1.5 nM, FAUC 346 with an inhibitory effect on cocaine-seeking behavior.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 43 | In Stock |
|
| 10MG | 70 | In Stock |
|
| 25MG | 141 | In Stock |
|
| 50MG | 231 | In Stock |
|
| 100MG | 370 | In Stock |
|
| 200MG | 507 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFAUC 346
-
NoteResearch use only, not for human use.
-
Brief DescriptionFAUC 346 is a highly selective D3 partial agonist with EC50 of 1.5 nM, FAUC 346 with an inhibitory effect on cocaine-seeking behavior.
-
DescriptionFAUC 346 is a highly selective D3 partial agonist with EC50 of 1.5 nM, FAUC 346 with an inhibitory effect on cocaine-seeking behavior.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorD3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number474432-65-0
-
Formula Weight423.57
-
Molecular FormulaC24H29N3O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (236.09 mM; Need ultrasonic)
-
SMILESO=C(C1=CC2=CC=CC=C2S1)NCCCCN3CCN(C4=CC=CC=C4OC)CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Carsten Hocke, et al. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor. ChemMedChem. 2008 May;3(5):788-93.
molnova catalog
related products
-
9-FLUORENOL
9-FLUORENOL is a dopamine reuptake inhibitor with IC50 of 9 μM, and a major metabolite of a compound developed as a wakefulness-promoting agent.
-
Sultopride hydrochlo...
Sultopride Hydrochloride is a selective dopamine D2 and D3 receptor antagonist.
-
Hirsuteine
Hirsuteine is a natural product. It non-competitively antagonizes nicotine-mediated dopamine release by blocking ion permeation through nicotinic receptor channel complexes.
